Medications

Nasal spray approved for treating suicidal people

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19's effect on the mental health of Americans.

Psychology & Psychiatry

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement—ketamine—shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Psychology & Psychiatry

Study shows important change in B-cells in women with PPD

A study published in Molecular Psychiatry is the first to look at multiple levels of biology within women with postpartum depression (PPD) to see how women with the condition differ from those without it. PPD affects 1 in ...

page 1 from 10